About Motus Gi
Motus Gi is a company based in Tirat Carmel (Israel) founded in 2008. Motus Gi has raised $30.08 million across 3 funding rounds from investors including Perceptive Advisors, Orchestra Medical Ventures and Ascent Biomedical Ventures. Motus Gi offers products and services including Pure-Vu EVS System. Motus Gi operates in a competitive market with competitors including SmartPill, LIMIS, NovaStoma, Health-Well and Magnexion, among others.
- Headquarter Tirat Carmel, Israel
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Motus Gi Holdings, Inc.
-
Annual Revenue
$319 K (USD)-46.11as on Dec 31, 2023
-
Net Profit
-$12.87 M (USD)30.81as on Dec 31, 2023
-
EBITDA
-$11.23 M (USD)34as on Dec 31, 2023
-
Total Equity Funding
$30.08 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Perceptive Advisors
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Motus Gi
Motus Gi is a publicly listed company on the OTC with ticker symbol MOTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Motus Gi
Motus Gi offers a comprehensive portfolio of products and services, including Pure-Vu EVS System.
Improves visualization by clearing debris during endoscopy and colonoscopy procedures.
People of Motus Gi
Unlock access to complete
Funding Insights of Motus Gi
Motus Gi has successfully raised a total of $30.08M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Motus Gi
Motus Gi has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Perceptive Advisors, Orchestra Medical Ventures and Ascent Biomedical Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Motus Gi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Motus Gi
Investment portfolio details for Motus Gi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Motus Gi
Detailed financials for Motus Gi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Motus Gi Comparisons
Peer comparison for Motus Gi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Motus Gi
Motus Gi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SmartPill, LIMIS, NovaStoma, Health-Well and Magnexion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of monitoring device for detecting gastrointestinal disorders
|
|
| Locked | Locked | Locked |
Surgical perfusion imaging devices are developed for colon tissue visualization.
|
|
| Locked | Locked | Locked |
Develops innovative devices to monitor stoma output effectively.
|
|
| Locked | Locked | Locked |
Creates innovative technologies for imaging devices and colon hydrotherapy.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for medical imaging devices focused on the gastrointestinal system.
|
Detailed competitors of Motus Gi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Motus Gi
Complete news archive for Motus Gi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Motus Gi
Motus Gi was founded in 2008 and raised its 1st funding round 8 years after it was founded.
Motus Gi is headquartered in Tirat Carmel, Israel. It is registered at Tirat Carmel, Haifa District, Israel.
Timothy P Moran is the current CEO of Motus Gi.
Motus Gi is a funded company, having raised a total of $30.08M across 3 funding rounds to date.
Annual revenue of Motus Gi is $319K as on Dec 31, 2023.
Motus-GIs first product the Pure-Vu, is designed to clean a poorly prepped colon during a colonoscopy procedure, which may reduce the dependency on a successful pre-procedural prep regimen to gain clear visualization of the colon mucosa. The system consists of a disposable single-use over-sleeve and a workstation controller. The disposable over-sleeve fits easily over standard colonoscopes and is connected to the workstation. Pure-Vu does not interfere with the working channel or the navigation or advancement of the colonoscope. The workstation controls a novel irrigation technology that creates a pulsed mixture of water and air through 4 jets to loosen fecal material and an efficient evacuation cycle that effectively removes considerable colon content. It also has an auto-purge technology to prevent clogging.
Motus Gi offers Pure-Vu EVS System.
Yes, Motus Gi is publicly traded on OTC under the ticker symbol MOTS.
Motus Gi has 5 investors. Key investors include Perceptive Advisors, Orchestra Medical Ventures, Ascent Biomedical Ventures, Jacobs Investments, and Pura Vida.
The ticker symbol of Motus Gi is MOTS on OTC.